Author

JP Lotz

Observed names: J-P Lotz, J-P. Lotz

Institutions: Assistance Publique – Hôpitaux de Paris, Hôpital Tenon

Observed institutions: University Medical Center Groningen, Leiden University Medical Center, Maastricht University Medical Centre, The Netherlands Cancer Institute, University Medical Center Utrecht, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Centre de Recherche en Cancérologie de Marseille, Erasmus MC Cancer Institute, Institut Paoli-Calmettes, University Hospital Cologne, Hôpital Tenon, Université Pierre-et-Marie-Curie

OpenAlex ID: A5111826930

Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations

2007 · E Foïs, M Desmartin, et al. · Bone Marrow Transplantation · 61

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

1998 · C Chabannon, K Cornetta, et al. · British Journal of Cancer · 24

PDF

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial

2000 · S Yanovich, P Mitsky, et al. · Bone Marrow Transplantation · 20

1619O High clinical benefit rates of single agent pembrolizumab in selected rare sarcoma histotypes: First results of the AcSé Pembrolizumab study

2020 · J-Y. Blay, S. Chevret, et al. · Annals of Oncology · 14

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

2005 · C Bengala, V Guarneri, et al. · Bone Marrow Transplantation · 13

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

2006 · J-P Lotz, P Pautier, et al. · Bone Marrow Transplantation · 5

711O Avelumab + methotrexate to eradicate low-risk gestational trophoblastic tumors in first-line setting: TROPHAMET phase I/II trial

2024 · B. You, J-P. Lotz, et al. · Annals of Oncology · 4

PDF

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

2006 · A Gonçalves, R Delva, et al. · Bone Marrow Transplantation · 4

Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

2018 · S Vliek, A Jager, et al. · Cancer Research · 3

Final Results From the ATALANTE/ENGOT-ov29 Randomized Phase III Trial of Atezolizumab, Bevacizumab, and Platinum-Based Therapy for Late-Relapsing Recurrent Ovarian Cancer

2026 · Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, et al. · JCO oncology advances. · 2

793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)

2023 · A.M. Catana, P-A. Just, et al. · Annals of Oncology · 2

PDF

1142P Dynamics and prognostic impact of HER3 expression in advanced ovarian cancer treated with neoadjuvant chemotherapy: Results from the CHIVA GINECO study

2025 · B.L. Alvarez Diaz, C. Genestie, et al. · Annals of Oncology · 1

LBA34 ENGOT-ov48/EUDARIO: European trial on enhanced DNA repair inhibition in ovarian cancer

2024 · N. Concin, T. Van Gorp, et al. · Annals of Oncology · 1

Outcomes of the combination trabectedin and pegylated liposomal doxorubicin (T-PLD) in recurrent platinum-sensitive ovarian cancer (OC): a GINECO cohort study

2017 · F. Selle, P-E. Heudel, et al. · Annals of Oncology · 1

PDF

47P Fertility and pregnancy outcomes after treatment with avelumab (anti-PD-L1) for gestational trophoblastic tumors: the FERTILAVE study

2026 · A. Msika, L. Eiriksson, et al. · ESMO rare cancers.

PDF

31MO Comparing efficacy of avelumab + methotrexate vs. methotrexate alone in low-risk gestational trophoblastic neoplasia: A national registry-based external control comparison

2026 · P-A. Bolze, O. Febvey-Combes, et al. · ESMO rare cancers.

PDF

1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic

2020 · P.R. Benusiglio, C. Korenbaum, et al. · Annals of Oncology

PDF

Abstract P2-16-06: Influence of trastuzumab pre-exposure in non metastatic disease to first line metastatic treatment efficacy including trastuzumab: The University Cancer Center - University Pierre & Marie Curie (IUC-UPMC) experience

2013 · J Gligorov, S Vignot, et al. · Cancer Research

Works count: 18

Citation count: 155

H-index: 5

I10-index: 5